Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03580785
Other study ID # 6641
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 22, 2018
Est. completion date October 12, 2023

Study information

Verified date August 2023
Source University Hospital, Strasbourg, France
Contact Marion STRUB, Doctor
Phone 388116956
Email marion.strub@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary purpose of the study is to identify clinical, radiological and genetic diagnostic criteria for Primary Failure of Eruption (PFE). The secondary purposes are to highlight the genotype-phenotype correlations in the PTHR1 and non-PTHR1 forms and analyze the therapeutic failures.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date October 12, 2023
Est. primary completion date October 12, 2023
Accepts healthy volunteers No
Gender All
Age group 6 Years and older
Eligibility Inclusion criteria: - people over 6 years old - people with Primary Failure Eruption Exclusion criteria: - children under 6 years old - endocrine pathology that may interfere with dental eruption - rickets - chemotherapy / radiotherapy - bisphosphonate treatment

Study Design


Related Conditions & MeSH terms


Intervention

Genetic:
genetic analysis
saliva is collected for DNA extraction
Radiation:
panoramic radiography
panoramic radiography
teleradiography
teleradiography
intraoral X-rays
intraoral X-rays
CT scan of maxillary and mandible
CT scan of maxillary and mandible

Locations

Country Name City State
France Clinique dentaire Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of teeth number of teeth at inclusion (day 1)
Primary Recording of dental caries recording of dental caries by Decayed Missing Filled Teeth index (DMFT index) at inclusion (day 1)
Primary Recording the location of dental caries the number of teeth affected using the international classification index at inclusion (day 1)
Primary Drugs intra uterine exposure drugs during pregnancy at inclusion (day 1)
Primary Nutritional deficiencies nutritional deficiencies assessed by a questionnaire at inclusion (day 1)
Primary Periodontium assessment of the periodontium by Maynard and Wilson classification at inclusion (day 1)
Primary Oral hygiene assesment of oral hygiene by plaque index (Löe and Silness, 1963) at inclusion (day 1)
Primary Gingival inflammation assesment of gingival inflammation by gingival index (Löe and Silness, 1963) at inclusion (day 1)
Primary Treatment needs assessment of treatment needs using Community Periodontal Index of treatment Needs (CPITN) at inclusion (day 1)
Primary Face shape assesment of the face shape : round, square, oval at inclusion (day 1)
Primary Symmetry of the face symmetry of the face (yes/no) at inclusion (day 1)
Primary Profile (shape) assessment of the profile (shape) at inclusion (day 1)
Primary Smile morphology of the smile at inclusion (day 1)
Primary Vertical dimension assessment of the vertical dimension: anterior infraclusion or overbite (in %) at inclusion (day 1)
Primary Transversal dimension assessment of the transversal dimension: posterior transversal dimension (in mm) at inclusion (day 1)
Primary Sagittal dimension Assessment of the sagittal dimension by Angle's classification at inclusion (day 1)
Primary Chewing Assessment of chewing by Plana's Functional Masticatory Angles (PFMA) at inclusion (day 1)
Primary Nasal breathing Assessment of nasal breathing by the Rosenthal's test at inclusion (day 1)
Primary Swallowing Assessment of swallowing by lingual interposition at inclusion (day 1)
Secondary Mutations causing PFE at inclusion (day 1)
Secondary Type of treatment performed (orthodontics, surgery, prothesis) at inclusion (day 1)